Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 243

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics

Open access
Saddoughi, Sahar A., Song, Pengfei, Ogretmen, Besim·2008·Subcellular Biochemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-1-4020-8831-5_16

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 165

  1. Abe, A., Radin, N.S., Shayman, J.A., Wotring, L.L., Zipkin, R.E., Sivakumar, R., Ruggieri, J.M., Carson, K.G., and Ganem, B. Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J Lipid Res, 36, 1995, 611–621. · DOI
  2. Akao, Y., Banno, Y., Nakagawa, Y., Hasegawa, N., Kim, T.J., Murate, T., Igarashi, Y., and Nozawa, Y. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem Biophys Res Commun, 342, 2006, 1284–1290. · DOI
  3. Alexander, S., Min, J., and Alexander, H. Dictyostelium discoideum to human cells: pharmacogenetic studies demonstrate a role for sphingolipids in chemoresistance. Biochim Biophys Acta, 1760, 2006, 301–309. · DOI
  4. Andrieu-Abadie, N. and Levade, T. Sphingomyelin hydrolysis during apoptosis. Biochim Biophys Acta, 1585, 2002, 126–134. · DOI · Paper page
  5. Argraves, K.M., Wilkerson, B.A., Argraves, W.S., Fleming, P.A., Obeid, L.M., and Drake, C.J. Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J Biol Chem, 279, 2004, 50580–50590. · DOI
  6. Baran, Y., Salas, A., Senkal, C.E., Gunduz, U., Bielawski, J., Obeid, L.M., and Ogretmen, B. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J Biol Chem, 282, 2007, 10922–10934. · DOI · Paper page
  7. Bektas, M., Jolly, P.S., Muller, C., Eberle, J., Spiegel, S., and Geilen, C.C. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene, 24, 2005, 178–187. · DOI
  8. Bieberich, E., Kawaguchi, T., and Yu, R.K. N-acylated serinol is a novel ceramide mimic inducing apoptosis in neuroblastoma cells. J Biol Chem, 275, 2000, 177–181. · DOI
  9. Bielawska, A., Greenberg, M.S., Perry, D., Jayadev, S., Shayman, J.A., McKay, C., and Hannun, Y.A. (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase. J Biol Chem, 271, 1996, 12646–12654. · DOI
  10. Bielawska, A., Bielawski, J., Szulc, Z.M., Mayroo, N., Liu, X., Bai, A., Elojeimy, S., Rembiesa, B., Pierce, J., Norris, J.S., and Hannun, Y.A. Novel analogs of d-e-MAPP and B13. Part 2: Signature effects on bioactive sphingolipids. Bioorg Med Chem, 16, 2008, 1032–1045. · DOI
  11. Birbes, H., El Bawab, S., Hannun, Y.A., and Obeid, L.M. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. Faseb J, 15, 2001, 2669–2679. · DOI · Paper page
  12. Blackburn, E.H. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett, 579, 2005, 859–862. · DOI · Paper page
  13. Borek, C. and Merrill, A.H., Jr. Sphingolipids inhibit multistage carcinogenesis and protein kinase C. Basic Life Sci, 61, 1993, 367–371.
  14. Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., and Kolesnick, R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell, 82, 1995, 405–414. · DOI · Paper page
  15. Bourbon, N.A., Sandirasegarane, L., and Kester, M. Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem, 277, 2002, 3286–3292. · DOI · Paper page
  16. Brinkmann, V., Cyster, J.G., and Hla, T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant, 4, 2004, 1019–1025. · DOI · Paper page
  17. Carracedo, A., Lorente, M., Egia, A., Blazquez, C., Garcia, S., Giroux, V., Malicet, C., Villuendas, R., Gironella, M., Gonzalez-Feria, L., Piris, M.A., Iovanna, J.L., Guzman, M., and Velasco, G. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell, 9, 2006, 301–312. · DOI · Paper page
  18. Cerantola, V., Vionnet, C., Aebischer, O.F., Jenny, T., Knudsen, J., and Conzelmann, A. Yeast sphingolipids do not need to contain very long chain fatty acids. Biochem J, 401, 2007, 205–216. · DOI
  19. Chae, S.S., Paik, J.H., Furneaux, H., and Hla, T. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest, 114, 2004, 1082–1089. · DOI · Paper page
  20. Chalfant, C.E., Ogretmen, B., Galadari, S., Kroesen, B.J., Pettus, B.J., and Hannun, Y.A. FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1. J Biol Chem, 276, 2001, 44848–44855. · DOI · Paper page
  21. Chalfant, C.E., Rathman, K., Pinkerman, R.L., Wood, R.E., Obeid, L.M., Ogretmen, B., and Hannun, Y.A. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem, 277, 2002, 12587–12595. · DOI · Paper page
  22. Charles, R., Sandirasegarane, L., Yun, J., Bourbon, N., Wilson, R., Rothstein, R.P., Levison, S.W., and Kester, M. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ Res, 87, 2000, 282–288. · DOI
  23. Chun, J. and Rosen, H. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases. Curr Pharm Des, 12, 2006, 161–171. · DOI
  24. Clarke, C.J. and Hannun, Y.A. Neutral sphingomyelinases and nSMase2: bridging the gaps. Biochim Biophys Acta, 1758, 2006, 1893–1901. · DOI
  25. Clarke, C.J., Snook, C.F., Tani, M., Matmati, N., Marchesini, N., and Hannun, Y.A. The extended family of neutral sphingomyelinases. Biochemistry, 45, 2006, 11247–11256. · DOI · Paper page
  26. Crawford, K.W., Bittman, R., Chun, J., Byun, H.S., and Bowen, W.D. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells. Cell Mol Biol (Noisy-le-grand), 49, 2003, 1017–1023.
  27. Cremesti, A., Paris, F., Grassme, H., Holler, N., Tschopp, J., Fuks, Z., Gulbins, E., and Kolesnick, R. Ceramide enables fas to cap and kill. J Biol Chem, 276, 2001, 23954–23961. · DOI · Paper page
  28. D'Angelo, G., Polishchuk, E., Di Tullio, G., Santoro, M., Di Campli, A., Godi, A., West, G., Bielawski, J., Chuang, C.C., van der Spoel, A.C., Platt, F.M., Hannun, Y.A., Polishchuk, R., Mattjus, P., and De Matteis, M.A. Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature, 449, 2007, 62–67. · DOI · Paper page
  29. Dahm, F., Bielawska, A., Nocito, A., Georgiev, P., Szulc, Z.M., Bielawski, J., Jochum, W., Dindo, D., Hannun, Y.A., and Clavien, P.A. Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice. Br J Cancer, 98, 2008, 98–105. · DOI
  30. Davis, M.D., Clemens, J.J., Macdonald, T.L., and Lynch, K.R. Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem, 280, 2005, 9833–9841. · DOI · Paper page
  31. Dbaibo, G.S., Pushkareva, M.Y., Jayadev, S., Schwarz, J.K., Horowitz, J.M., Obeid, L.M., and Hannun, Y.A. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci U S A, 92, 1995, 1347–1351. · DOI · Paper page
  32. Dbaibo, G.S., Perry, D.K., Gamard, C.J., Platt, R., Poirier, G.G., Obeid, L.M., and Hannun, Y.A. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med, 185, 1997, 481–490. · DOI · Paper page
  33. De Rosa, M.F., Sillence, D., Ackerley, C., and Lingwood, C. Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis. J Biol Chem, 279, 2004, 7867–7876. · DOI
  34. Dindo, D., Dahm, F., Szulc, Z., Bielawska, A., Obeid, L.M., Hannun, Y.A., Graf, R., and Clavien, P.A. Cationic long-chain ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells. Mol Cancer Ther, 5, 2006, 1520–1529. · DOI
  35. Dobrowsky, R.T. and Hannun, Y.A. Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem, 267, 1992, 5048–5051. · DOI · Paper page
  36. Dobrowsky, R.T., Kamibayashi, C., Mumby, M.C., and Hannun, Y.A. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem, 268, 1993, 15523–15530. · DOI · Paper page
  37. Dobrowsky, R.T., Werner, M.H., Castellino, A.M., Chao, M.V., and Hannun, Y.A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science, 265, 1994, 1596–1599. · DOI · Paper page
  38. Dolgachev, V., Farooqui, M.S., Kulaeva, O.I., Tainsky, M.A., Nagy, B., Hanada, K., and Separovic, D. De novo ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells. J Biol Chem, 279, 2004, 23238–23249. · DOI
  39. Fishbein, J.D., Dobrowsky, R.T., Bielawska, A., Garrett, S., and Hannun, Y.A. Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae. J Biol Chem, 268, 1993, 9255–9261. · DOI
  40. Fox, T.E., Finnegan, C.M., Blumenthal, R., and Kester, M. The clinical potential of sphingolipid-based therapeutics. Cell Mol Life Sci, 63, 2006, 1017–1023. · DOI
  41. Fox, T.E., Houck, K.L., O'Neill, S.M., Nagarajan, M., Stover, T.C., Pomianowski, P.T., Unal, O., Yun, J.K., Naides, S.J., and Kester, M. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J Biol Chem, 282, 2007, 12450–12457. · DOI · Paper page
  42. French, K.J., Upson, J.J., Keller, S.N., Zhuang, Y., Yun, J.K., and Smith, C.D. Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther, 318, 2006, 596–603. · DOI · Paper page
  43. Futerman, A.H. and Hannun, Y.A. The complex life of simple sphingolipids. EMBO Rep, 5, 2004, 777–782. · DOI · Paper page
  44. Futerman, A.H. and Riezman, H. The ins and outs of sphingolipid synthesis. Trends Cell Biol, 15, 2005, 312–318. · DOI · Paper page
  45. Gouaze-Andersson, V. and Cabot, M.C. Glycosphingolipids and drug resistance. Biochim Biophys Acta, 1758, 2006, 2096–2103. · DOI
  46. Gouaze-Andersson, V., Yu, J.Y., Kreitenberg, A.J., Bielawska, A., Giuliano, A.E., and Cabot, M.C. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells. Biochim Biophys Acta, 1771, 2007, 1407–1417. · DOI
  47. Gouaze, V., Liu, Y.Y., Prickett, C.S., Yu, J.Y., Giuliano, A.E., and Cabot, M.C. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res, 65, 2005, 3861–3867. · DOI · Paper page
  48. Gouaze, V., Yu, J.Y., Bleicher, R.J., Han, T.Y., Liu, Y.Y., Wang, H., Gottesman, M.M., Bitterman, A., Giuliano, A.E., and Cabot, M.C. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther, 3, 2004, 633–639. · DOI
  49. Goulding, C.W., Giuliano, A.E., and Cabot, M.C. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein. Cancer Lett, 149, 2000, 143–151. · doi:10.1016/s0304-3835(99)00353-5
  50. Guillas, I., Kirchman, P.A., Chuard, R., Pfefferli, M., Jiang, J.C., Jazwinski, S.M., and Conzelmann, A. C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. Embo J, 20, 2001, 2655–2665. · DOI · Paper page
  51. Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M., and Nishijima, M. Molecular machinery for non-vesicular trafficking of ceramide. Nature, 426, 2003, 803–809. · DOI · Paper page
  52. Hannun, Y.A. and Obeid, L.M. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem, 277, 2002, 25847–25850. · DOI · Paper page
  53. Heinrich, M., Neumeyer, J., Jakob, M., Hallas, C., Tchikov, V., Winoto-Morbach, S., Wickel, M., Schneider-Brachert, W., Trauzold, A., Hethke, A., and Schutze, S. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ, 11, 2004, 550–563. · DOI · Paper page
  54. Herrera, B., Carracedo, A., Diez-Zaera, M., Gomez del Pulgar, T., Guzman, M., and Velasco, G. The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. Exp Cell Res, 312, 2006, 2121–2131. · DOI
  55. Hinrichs, J.W., Klappe, K., and Kok, J.W. Rafts as missing link between multidrug resistance and sphingolipid metabolism. J Membr Biol, 203, 2005, 57–64. · doi:10.1007/s00232-004-0733-4
  56. Hla, T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol, 15, 2004, 513–520. · DOI · Paper page
  57. Holman, D.H., Turner, L.S., El-Zawahry, A., Elojeimy, S., Liu, X., Bielawski, J., Szulc, Z.M., Norris, K., Zeidan, Y.H., Hannun, Y.A., Bielawska, A., and Norris, J.S. Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. Cancer Chemother Pharmacol, 61, 2008, 231–242. · DOI
  58. Jazwinski, S.M. and Conzelmann, A. LAG1 puts the focus on ceramide signaling. Int J Biochem Cell Biol, 34, 2002, 1491–1495. · DOI
  59. Jiang, Q., Wong, J., Fyrst, H., Saba, J.D., and Ames, B.N. gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci U S A, 101, 2004, 17825–17830. · DOI · Paper page
  60. Kageyama-Yahara, N. and Riezman, H. Transmembrane topology of ceramide synthase in yeast. Biochem J, 398, 2006, 585–593. · DOI
  61. Karahatay, S., Thomas, K., Koybasi, S., Senkal, C.E., Elojeimy, S., Liu, X., Bielawski, J., Day, T.A., Gillespie, M.B., Sinha, D., Norris, J.S., Hannun, Y.A., and Ogretmen, B. Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett, 256, 2007, 101–111. · DOI · Paper page
  62. Kawamori, T., Osta, W., Johnson, K.R., Pettus, B.J., Bielawski, J., Tanaka, T., Wargovich, M.J., Reddy, B.S., Hannun, Y.A., Obeid, L.M., and Zhou, D. Sphingosine kinase 1 is up-regulated in colon carcinogenesis. Faseb J, 20, 2006, 386–388. · DOI · Paper page
  63. Kok, J.W. and Sietsma, H. Sphingolipid metabolism enzymes as targets for anticancer therapy. Curr Drug Targets, 5, 2004, 375–382. · doi:10.2174/1389450043345452
  64. Koybasi, S., Senkal, C.E., Sundararaj, K., Spassieva, S., Bielawski, J., Osta, W., Day, T.A., Jiang, J.C., Jazwinski, S.M., Hannun, Y.A., Obeid, L.M., and Ogretmen, B. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem, 279, 2004, 44311–44319. · DOI · Paper page
  65. Kraveka, J.M., Li, L., Szulc, Z.M., Bielawski, J., Ogretmen, B., Hannun, Y.A., Obeid, L.M., and Bielawska, A. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J Biol Chem, 282, 2007, 16718–16728. · DOI · Paper page
  66. Kudo, N., Kumagai, K., Tomishige, N., Yamaji, T., Wakatsuki, S., Nishijima, M., Hanada, K., and Kato, R. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A, 105, 2008, 488–493. · DOI · Paper page
  67. Kumagai, K., Yasuda, S., Okemoto, K., Nishijima, M., Kobayashi, S., and Hanada, K. CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem, 280, 2005, 6488–6495. · DOI · Paper page
  68. Lahiri, S. and Futerman, A.H. LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor. J Biol Chem, 280, 2005, 33735–33738. · DOI
  69. LaMontagne, K., Littlewood-Evans, A., Schnell, C., O'Reilly, T., Wyder, L., Sanchez, T., Probst, B., Butler, J., Wood, A., Liau, G., Billy, E., Theuer, A., Hla, T., and Wood, J. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res, 66, 2006, 221–231. · DOI · Paper page
  70. Laviad, E.L., Albee, L., Pankova-Kholmyansky, I., Epstein, S., Park, H., Merrill, A.H., Jr., and Futerman, A.H. Characterization of ceramide synthase 2: Tissue distribution, substrate specificity and inhibition by sphingosine 1-phosphate. J Biol Chem 2007, in press. · DOI · Paper page
  71. Lee, J.Y., Bielawska, A.E., and Obeid, L.M. Regulation of cyclin-dependent kinase 2 activity by ceramide. Exp Cell Res, 261, 2000, 303–311. · DOI
  72. Lee, S.J. Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. Proc Natl Acad Sci U S A, 88, 1991, 4250–4254. · DOI · Paper page
  73. Liu, H., Toman, R.E., Goparaju, S.K., Maceyka, M., Nava, V.E., Sankala, H., Payne, S.G., Bektas, M., Ishii, I., Chun, J., Milstien, S., and Spiegel, S. Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem, 278, 2003, 40330–40336. · DOI · Paper page
  74. Liu, X., Elojeimy, S., Turner, L.S., Mahdy, A.E., Zeidan, Y.H., Bielawska, A., Bielawski, J., Dong, J.Y., El-Zawahry, A.M., Guo, G.W., Hannun, Y.A., Holman, D.H., Rubinchik, S., Szulc, Z., Keane, T.E., Tavassoli, M., and Norris, J.S. Acid ceramidase inhibition: a novel target for cancer therapy. Front Biosci, 13, 2008, 2293–2298. · doi:10.2741/2843
  75. Maceyka, M., Payne, S.G., Milstien, S., and Spiegel, S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta, 1585, 2002, 193–201. · DOI · Paper page
  76. Maurer, B.J., Metelitsa, L.S., Seeger, R.C., Cabot, M.C., and Reynolds, C.P. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst, 91, 1999, 1138–1146. · doi:10.1093/jnci/91.13.1138
  77. Maurer, B.J., Melton, L., Billups, C., Cabot, M.C., and Reynolds, C.P. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. J Natl Cancer Inst, 92, 2000, 1897–1909. · DOI · Paper page
  78. Meng, A., Luberto, C., Meier, P., Bai, A., Yang, X., Hannun, Y.A., and Zhou, D. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. Exp Cell Res, 292, 2004, 385–392. · DOI
  79. Merrill, A.H., Jr., Wang, E., and Mullins, R.E. Kinetics of long-chain (sphingoid) base biosynthesis in intact LM cells: effects of varying the extracellular concentrations of serine and fatty acid precursors of this pathway. Biochemistry, 27, 1988, 340–345. · doi:10.1021/bi00401a051
  80. Mesika, A., Ben-Dor, S., Laviad, E.L., and Futerman, A.H. A new functional motif in Hox domain-containing ceramide synthases: identification of a novel region flanking the Hox and TLC domains essential for activity. J Biol Chem, 282, 2007, 27366–27373. · DOI
  81. Michel, C., van Echten-Deckert, G., Rother, J., Sandhoff, K., Wang, E., and Merrill, A.H., Jr. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem, 272, 1997, 22432–22437. · DOI · Paper page
  82. Min, J., Van Veldhoven, P.P., Zhang, L., Hanigan, M.H., Alexander, H., and Alexander, S. Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Mol Cancer Res, 3, 2005, 287–296. · DOI
  83. Min, J., Mesika, A., Sivaguru, M., Van Veldhoven, P.P., Alexander, H., Futerman, A.H., and Alexander, S. (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. Mol Cancer Res, 5, 2007, 801–812. · DOI
  84. Minutolo, F., Sala, G., Bagnacani, A., Bertini, S., Carboni, I., Placanica, G., Prota, G., Rapposelli, S., Sacchi, N., Macchia, M., and Ghidoni, R. Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells. J Med Chem, 48, 2005, 6783–6786. · DOI
  85. Mitra, P., Maceyka, M., Payne, S.G., Lamour, N., Milstien, S., Chalfant, C.E., and Spiegel, S. Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells. FEBS Lett, 581, 2007, 735–740. · DOI
  86. Mizugishi, K., Yamashita, T., Olivera, A., Miller, G.F., Spiegel, S., and Proia, R.L. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol, 25, 2005, 11113–11121. · DOI · Paper page
  87. Mizutani, Y., Kihara, A., and Igarashi, Y. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J, 390, 2005, 263–271. · DOI · Paper page
  88. Modica-Napolitano, J.S. and Aprille, J.R. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Deliv Rev, 49, 2001, 63–70. · DOI · Paper page
  89. Modrak, D.E., Gold, D.V., and Goldenberg, D.M. Sphingolipid targets in cancer therapy. Mol Cancer Ther, 5, 2006, 200–208. · doi:10.1158/1535-7163.mct-05-0420
  90. Modrak, D.E., Cardillo, T.M., Newsome, G.A., Goldenberg, D.M., and Gold, D.V. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. Cancer Res, 64, 2004, 8405–8410. · DOI
  91. Morales, A., Paris, R., Villanueva, A., Llacuna, L., Garcia-Ruiz, C., and Fernandez-Checa, J.C. Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. Oncogene, 26, 2007, 905–916. · DOI
  92. Nagiec, M.M., Lester, R.L., and Dickson, R.C. Sphingolipid synthesis: identification and characterization of mammalian cDNAs encoding the Lcb2 subunit of serine palmitoyltransferase. Gene, 177, 1996, 237–241. · doi:10.1016/0378-1119(96)00309-5
  93. Nava, V.E., Hobson, J.P., Murthy, S., Milstien, S., and Spiegel, S. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res, 281, 2002, 115–127. · DOI · Paper page
  94. Norris-Cervetto, E., Callaghan, R., Platt, F.M., Dwek, R.A., and Butters, T.D. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells. J Biol Chem, 279, 2004, 40412–40418. · doi:10.1074/jbc.m404466200
  95. Novgorodov, S.A., Szulc, Z.M., Luberto, C., Jones, J.A., Bielawski, J., Bielawska, A., Hannun, Y.A., and Obeid, L.M. Positively charged ceramide is a potent inducer of mitochondrial permeabilization. J Biol Chem, 280, 2005, 16096–16105. · DOI
  96. Obeid, L.M. and Hannun, Y.A. Ceramide, stress, and a "LAG" in aging. Sci Aging Knowledge Environ, 2003, 2003, pe27. · DOI
  97. Ogretmen, B. Sphingolipids in cancer: regulation of pathogenesis and therapy. FEBS Lett, 580, 2006, 5467–5476. · DOI
  98. Ogretmen, B. and Hannun, Y.A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer, 4, 2004, 604–616. · DOI · Paper page
  99. Ogretmen, B. and Hannun, Y.A. Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance. Drug Resist Updat, 4, 2001, 368–377. · DOI
  100. Ogretmen, B., Kraveka, J.M., Schady, D., Usta, J., Hannun, Y.A., and Obeid, L.M. Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line. J Biol Chem, 276, 2001a, 32506–32514. · DOI
  101. Ogretmen, B., Schady, D., Usta, J., Wood, R., Kraveka, J.M., Luberto, C., Birbes, H., Hannun, Y.A., and Obeid, L.M. Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells. J Biol Chem, 276, 2001b, 24901–24910. · DOI
  102. Ogretmen, B., Pettus, B.J., Rossi, M.J., Wood, R., Usta, J., Szulc, Z., Bielawska, A., Obeid, L.M., and Hannun, Y.A. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide. J Biol Chem, 277, 2002, 12960–12969. · DOI · Paper page
  103. Okazaki, T., Bell, R.M., and Hannun, Y.A. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem, 264, 1989, 19076–19080. · DOI · Paper page
  104. Oskouian, B., Sooriyakumaran, P., Borowsky, A.D., Crans, A., Dillard-Telm, L., Tam, Y.Y., Bandhuvula, P., and Saba, J.D. Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc Natl Acad Sci U S A, 103, 2006, 17384–17389. · DOI · Paper page
  105. Park, J.H. and Schuchman, E.H. Acid ceramidase and human disease. Biochim Biophys Acta, 1758, 2006, 2133–2138. · DOI · Paper page
  106. Paugh, S.W., Payne, S.G., Barbour, S.E., Milstien, S., and Spiegel, S. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett, 554, 2003, 189–193. · DOI · Paper page
  107. Pchejetski, D., Golzio, M., Bonhoure, E., Calvet, C., Doumerc, N., Garcia, V., Mazerolles, C., Rischmann, P., Teissie, J., Malavaud, B., and Cuvillier, O. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res, 65, 2005, 11667–11675. · DOI · Paper page
  108. Pettus, B.J., Chalfant, C.E., and Hannun, Y.A. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta, 1585, 2002, 114–125. · DOI · Paper page
  109. Pettus, B.J., Bielawski, J., Porcelli, A.M., Reames, D.L., Johnson, K.R., Morrow, J., Chalfant, C.E., Obeid, L.M., and Hannun, Y.A. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. Faseb J, 17, 2003, 1411–1421. · DOI · Paper page
  110. Plo, I., Ghandour, S., Feutz, A.C., Clanet, M., Laurent, G., and Bettaieb, A. Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death. Neuroreport, 10, 1999, 2373–2376. · DOI
  111. Radin, N.S. The development of aggressive cancer: a possible role for sphingolipids. Cancer Invest, 20, 2002, 779–786. · DOI
  112. Raisova, M., Bektas, M., Wieder, T., Daniel, P., Eberle, J., Orfanos, C.E., and Geilen, C.C. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett, 473, 2000, 27–32. · DOI
  113. Rao, R.P., Yuan, C., Allegood, J.C., Rawat, S.S., Edwards, M.B., Wang, X., Merrill, A.H., Jr., Acharya, U., and Acharya, J.K. Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc Natl Acad Sci U S A, 104, 2007, 11364–11369. · DOI
  114. Reynolds, C.P., Maurer, B.J., and Kolesnick, R.N. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett, 206, 2004, 169–180. · DOI
  115. Riebeling, C., Allegood, J.C., Wang, E., Merrill, A.H., Jr., and Futerman, A.H. Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem, 278, 2003, 43452–43459. · DOI · Paper page
  116. Rosen, H. and Goetzl, E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol, 5, 2005, 560–570. · DOI · Paper page
  117. Rossi, M.J., Sundararaj, K., Koybasi, S., Phillips, M.S., Szulc, Z.M., Bielawska, A., Day, T.A., Obeid, L.M., Hannun, Y.A., and Ogretmen, B. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg, 132, 2005, 55–62. · doi:10.1016/j.otohns.2004.08.015
  118. Saad, A.F., Meacham, W.D., Bai, A., Anelli, V., Elojeimy, S., Mahdy, A.E., Turner, L.S., Cheng, J., Bielawska, A., Bielawski, J., Keane, T.E., Obeid, L.M., Hannun, Y.A., Norris, J.S., and Liu, X. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy. Cancer Biol Ther, 6, 2007, 1455–1460. · DOI
  119. Samsel, L., Zaidel, G., Drumgoole, H.M., Jelovac, D., Drachenberg, C., Rhee, J.G., Brodie, A.M., Bielawska, A., and Smyth, M.J. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate, 58, 2004, 382–393. · DOI
  120. Sankala, H.M., Hait, N.C., Paugh, S.W., Shida, D., Lepine, S., Elmore, L.W., Dent, P., Milstien, S., and Spiegel, S. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res, 67, 2007, 10466–10474. · DOI · Paper page
  121. Santana, P., Pena, L.A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E.H., Fuks, Z., and Kolesnick, R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell, 86, 1996, 189–199. · DOI · Paper page
  122. Sarkar, S., Maceyka, M., Hait, N.C., Paugh, S.W., Sankala, H., Milstien, S., and Spiegel, S. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett, 579, 2005, 5313–5317. · DOI · Paper page
  123. Scarlatti, F., Sala, G., Somenzi, G., Signorelli, P., Sacchi, N., and Ghidoni, R. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. Faseb J, 17, 2003, 2339–2341. · DOI · Paper page
  124. Scarlatti, F., Sala, G., Ricci, C., Maioli, C., Milani, F., Minella, M., Botturi, M., and Ghidoni, R. Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Cancer Lett, 253, 2007, 124–130. · DOI
  125. Schmelz, E.M., Sullards, M.C., Dillehay, D.L., and Merrill, A.H., Jr. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J Nutr, 130, 2000, 522–527. · doi:10.1093/jn/130.3.522
  126. Schmelz, E.M., Dillehay, D.L., Webb, S.K., Reiter, A., Adams, J., and Merrill, A.H., Jr. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res, 56, 1996, 4936–4941.
  127. Schulz, A., Mousallem, T., Venkataramani, M., Persaud-Sawin, D.A., Zucker, A., Luberto, C., Bielawska, A., Bielawski, J., Holthuis, J.C., Jazwinski, S.M., Kozhaya, L., Dbaibo, G.S., and Boustany, R.M. The CLN9 protein, a regulator of dihydroceramide synthase. J Biol Chem, 281, 2006, 2784–2794. · DOI
  128. Segui, B., Cuvillier, O., Adam-Klages, S., Garcia, V., Malagarie-Cazenave, S., Leveque, S., Caspar-Bauguil, S., Coudert, J., Salvayre, R., Kronke, M., and Levade, T. Involvement of FAN in TNF-induced apoptosis. J Clin Invest, 108, 2001, 143–151. · DOI
  129. Selzner, M., Bielawska, A., Morse, M.A., Rudiger, H.A., Sindram, D., Hannun, Y.A., and Clavien, P.A. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res, 61, 2001, 1233–1240.
  130. Senchenkov, A., Litvak, D.A., and Cabot, M.C. Targeting ceramide metabolism--a strategy for overcoming drug resistance. J Natl Cancer Inst, 93, 2001, 347–357. · doi:10.1093/jnci/93.5.347
  131. Senkal, C.E., Ponnusamy, S., Rossi, M.J., Bialewski, J., Sinha, D., Jiang, J.C., Jazwinski, S.M., Hannun, Y.A., and Ogretmen, B. Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther, 6, 2007, 712–722. · DOI · Paper page
  132. Senkal, C.E., Ponnusamy, S., Rossi, M.J., Sundararaj, K., Szulc, Z., Bielawski, J., Bielawska, A., Meyer, M., Cobanoglu, B., Koybasi, S., Sinha, D., Day, T.A., Obeid, L.M., Hannun, Y.A., and Ogretmen, B. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo. J Pharmacol Exp Ther, 317, 2006, 1188–1199. · DOI
  133. Smyth, M.J., Perry, D.K., Zhang, J., Poirier, G.G., Hannun, Y.A., and Obeid, L.M. prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J, 316 (Pt 1), 1996, 25–28. · DOI · Paper page
  134. Snook, C.F., Jones, J.A., and Hannun, Y.A. Sphingolipid-binding proteins. Biochim Biophys Acta, 1761, 2006, 927–946. · DOI
  135. Stover, T. and Kester, M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther, 307, 2003, 468–475. · doi:10.1124/jpet.103.054056
  136. Stover, T.C., Sharma, A., Robertson, G.P., and Kester, M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res, 11, 2005, 3465–3474. · DOI · Paper page
  137. Struckhoff, A.P., Bittman, R., Burow, M.E., Clejan, S., Elliott, S., Hammond, T., Tang, Y., and Beckman, B.S. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. J Pharmacol Exp Ther, 309, 2004, 523–532. · DOI
  138. Sugiura, M., Kono, K., Liu, H., Shimizugawa, T., Minekura, H., Spiegel, S., and Kohama, T. Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. J Biol Chem, 277, 2002, 23294–23300. · DOI · Paper page
  139. Sultan, I., Senkal, C.E., Ponnusamy, S., Bielawski, J., Szulc, Z., Bielawska, A., Hannun, Y.A., and Ogretmen, B. Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function. Biochem J, 393, 2006, 513–521. · DOI
  140. Sundararaj, K.P., Wood, R.E., Ponnusamy, S., Salas, A.M., Szulc, Z., Bielawska, A., Obeid, L.M., Hannun, Y.A., and Ogretmen, B. Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem, 279, 2004, 6152–6162. · DOI
  141. Suomalainen, L., Pentikainen, V., and Dunkel, L. Sphingosine-1-phosphate inhibits nuclear factor kappaB activation and germ cell apoptosis in the human testis independently of its receptors. Am J Pathol, 166, 2005, 773–781. · doi:10.1016/s0002-9440(10)62298-5
  142. Swanton, C., Marani, M., Pardo, O., Warne, P.H., Kelly, G., Sahai, E., Elustondo, F., Chang, J., Temple, J., Ahmed, A.A., Brenton, J.D., Downward, J., and Nicke, B. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell, 11, 2007, 498–512. · DOI · Paper page
  143. Szulc, Z.M., Bielawski, J., Gracz, H., Gustilo, M., Mayroo, N., Hannun, Y.A., Obeid, L.M., and Bielawska, A. Tailoring structure-function and targeting properties of ceramides by site-specific cationization. Bioorg Med Chem, 14, 2006, 7083–7104. · DOI
  144. Taha, T.A., Hannun, Y.A., and Obeid, L.M. Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol, 39, 2006a, 113–131.
  145. Taha, T.A., Kitatani, K., El-Alwani, M., Bielawski, J., Hannun, Y.A., and Obeid, L.M. Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis. Faseb J, 20, 2006b, 482–484. · DOI
  146. Testai, F.D., Landek, M.A., and Dawson, G. Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. J Neurosci Res, 75, 2004, 66–74. · DOI
  147. Thomas, D.A., Sarris, A.H., Cortes, J., Faderl, S., O'Brien, S., Giles, F.J., Garcia-Manero, G., Rodriguez, M.A., Cabanillas, F., and Kantarjian, H. Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia. Cancer, 106, 2006, 120–127. · DOI
  148. Thon, L., Mohlig, H., Mathieu, S., Lange, A., Bulanova, E., Winoto-Morbach, S., Schutze, S., Bulfone-Paus, S., and Adam, D. Ceramide mediates caspase-independent programmed cell death. Faseb J, 19, 2005, 1945–1956. · DOI
  149. Tilly, J.L. and Kolesnick, R.N. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim Biophys Acta, 1585, 2002, 135–138. · doi:10.1016/s1388-1981(02)00333-5
  150. Van Brocklyn, J., Letterle, C., Snyder, P., and Prior, T. Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. Cancer Lett, 181, 2002, 195–204. · doi:10.1016/s0304-3835(02)00050-2
  151. Van der Luit, A.H., Budde, M., Zerp, S., Caan, W., Klarenbeek, J.B., Verheij, M., and Van Blitterswijk, W.J. Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts. Biochem J, 401, 2007, 541–549. · DOI
  152. van Vlerken, L.E., Duan, Z., Seiden, M.V., and Amiji, M.M. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res, 67, 2007, 4843–4850. · DOI · Paper page
  153. Veldman, R.J., Zerp, S., van Blitterswijk, W.J., and Verheij, M. N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx. Br J Cancer, 90, 2004, 917–925. · DOI
  154. Veldman, R.J., Mita, A., Cuvillier, O., Garcia, V., Klappe, K., Medin, J.A., Campbell, J.D., Carpentier, S., Kok, J.W., and Levade, T. The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs. Faseb J, 17, 2003, 1144–1146. · DOI
  155. Venable, M.E., Lee, J.Y., Smyth, M.J., Bielawska, A., and Obeid, L.M. Role of ceramide in cellular senescence. J Biol Chem, 270, 1995, 30701–30708. · DOI · Paper page
  156. Venkataraman, K., Riebeling, C., Bodennec, J., Riezman, H., Allegood, J.C., Sullards, M.C., Merrill, A.H., Jr., and Futerman, A.H. Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J Biol Chem, 277, 2002, 35642–35649. · DOI · Paper page
  157. Visentin, B., Vekich, J.A., Sibbald, B.J., Cavalli, A.L., Moreno, K.M., Matteo, R.G., Garland, W.A., Lu, Y., Yu, S., Hall, H.S., Kundra, V., Mills, G.B., and Sabbadini, R.A. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell, 9, 2006, 225–238. · DOI · Paper page
  158. Wang, G., Silva, J., Krishnamurthy, K., Tran, E., Condie, B.G., and Bieberich, E. Direct binding to ceramide activates protein kinase Czeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells. J Biol Chem, 280, 2005, 26415–26424. · DOI
  159. Wang, H., Maurer, B.J., Reynolds, C.P., and Cabot, M.C. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. Cancer Res, 61, 2001, 5102–5105.
  160. Wolff, R.A., Dobrowsky, R.T., Bielawska, A., Obeid, L.M., and Hannun, Y.A. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem, 269, 1994, 19605–19609. · DOI · Paper page
  161. Wooten-Blanks, L.G., Song, P., Senkal, C.E., and Ogretmen, B. Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1. Faseb J, 21, 2007, 3386–3397. · DOI
  162. Wooten, L.G. and Ogretmen, B. Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide. J Biol Chem, 280, 2005, 28867–28876. · DOI
  163. Xia, P., Gamble, J.R., Wang, L., Pitson, S.M., Moretti, P.A., Wattenberg, B.W., D'Andrea, R.J., and Vadas, M.A. An oncogenic role of sphingosine kinase. Curr Biol, 10, 2000, 1527–1530. · DOI · Paper page
  164. Zhang, P., Liu, B., Jenkins, G.M., Hannun, Y.A., and Obeid, L.M. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J Biol Chem, 272, 1997, 9609–9612. · DOI
  165. Zheng, W., Kollmeyer, J., Symolon, H., Momin, A., Munter, E., Wang, E., Kelly, S., Allegood, J.C., Liu, Y., Peng, Q., Ramaraju, H., Sullards, M.C., Cabot, M., and Merrill, A.H., Jr. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta, 1758, 2006, 1864–1884. · DOI · Paper page

Cited by

See all 243

Metadata

Authors
Saddoughi, S. A., Song, P., & Ogretmen, B.
Venue
Subcellular Biochemistry
Published
2008-08-26
Volume
49
Pages
413-440
ISSN
0306-0225 (ISSN-L)
OpenAlex
W94821320
Cited by
243
References
3
FWCI
31.09
Type
book chapter
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics. https://app.cochat.ai/papers/10.1007/978-1-4020-8831-5_16
The paper
Saddoughi, S. A., Song, P., & Ogretmen, B. (2008). Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics. Subcellular Biochemistry. https://doi.org/10.1007/978-1-4020-8831-5_16

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.